Getwell Pharma India Profile
Key Indicators
- Authorised Capital ₹ 32.50 Cr
- Paid Up Capital ₹ 31.30 Cr
- Company Age 8 Year, 13 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 42.19 Cr
- Revenue Growth -59.90%
- Profit Growth 1543.08%
- Ebitda -334.19%
- Net Worth 20.18%
- Total Assets 69.09%
About Getwell Pharma India
Getwell Pharma India Private Limited (GPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 January 2017 (Eight years 13 days old ). Its registered office is in Delhi, India.
The Corporate was formerly known as Getwellpharma India Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 32.50 Cr and a paid-up capital of Rs 31.30 Cr.
The company currently has active open charges totaling ₹42.19 Cr.
The Key Managerial Personnel (KMP) at Getwell Pharma India Private Limited India is Sonia Ahuja as COMPANY SECRETARY. Rakesh Dwivedi, Prerna Tandon, Mini Tandon, and One other member serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24290DL2017PTC310791
-
Company No.
310791
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Jan 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Getwell Pharma India Private Limited offer?
Getwell Pharma India Private Limited offers a wide range of products and services, including Towels, Napkins & Handkerchieves, Face and Hand Towels, TB, Tumor & Cancer Drugs, Anti Cancer Injection, Anti Cancer Medicines.
Who are the key members and board of directors at Getwell Pharma India?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sonia Ahuja | Company Secretary | 01-Feb-2021 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mini Tandon | Director | 19-Jan-2017 | Current |
Rakesh Dwivedi | Director | 16-Oct-2023 | Current |
Prerna Tandon | Additional Director | 15-Apr-2022 | Current |
Manas Tandon | Director | 19-Jan-2017 | Current |
Financial Performance of Getwell Pharma India.
Getwell Pharma India Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 59.9% decrease. The company also saw a substantial improvement in profitability, with a 1543.08% increase in profit. The company's net worth Soared by an impressive increase of 20.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Getwell Pharma India?
In 2022, Getwell Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹42.19 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 42.05 Cr
- Hdfc Bank Limited : 0.14 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
13 Nov 2024 | State Bank Of India | ₹9.00 M | Open |
23 Feb 2024 | State Bank Of India | ₹0.58 M | Open |
03 Aug 2023 | Hdfc Bank Limited | ₹1.44 M | Open |
31 May 2022 | State Bank Of India | ₹3.50 Cr | Open |
22 Jul 2020 | State Bank Of India | ₹1.40 Cr | Open |
How Many Employees Work at Getwell Pharma India?
Getwell Pharma India has a workforce of 111 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Getwell Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Getwell Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.